Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
28%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
PPH
27
HOLDINGS
21%
ALSO IN THNR
THNR
19
HOLDINGS
26%
ALSO IN PPH
SECTOR DRIFT (PPH minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 18.6% | 8.4% | 8.4% |
|
MERCK & CO. INC. | 11.0% | 5.5% | 5.5% |
 |
NOVO-NORDISK A/S-SPONS ADR | 5.0% | 9.0% | 5.0% |
|
PFIZER INC | 5.1% | 4.9% | 4.9% |
|
ABBVIE INC | 4.5% | 5.0% | 4.5% |
PPH Overweight Relative to THNR
 |
NOVARTIS AG-ADR | 10.4% |
|
ELI LILLY & CO | 10.2% |
|
MERCK & CO. INC. | 5.6% |
|
BRISTOL-MYERS SQUIBB CO | 5.0% |
|
MCKESSON CORP | 4.7% |
|
JOHNSON & JOHNSON | 4.5% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | 4.0% |
 |
SANOFI-AVENTIS-ADR | 4.0% |
|
CENCORA INC | 3.8% |
|
ASTRAZENECA PLC-SPONS ADR | 3.6% |
PPH Underweight Relative to THNR
 |
INNOVENT BIOLOGICS, INC. | -6.1% |
|
REGENERON PHARMACEUTICALS | -6.1% |
 |
CHINA PHARMACEUTICAL GROUP | -5.9% |
|
AMGEN INC | -5.6% |
|
SCHOLAR ROCK HOLDING CORP. | -5.4% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -5.1% |
|
VIKING THERAPEUTICS, INC. | -4.7% |
|
HIMS & HERS HEALTH, INC. CLASS A | -4.2% |
|
ASTRAZENECA PLC | -4.0% |
|
NOVO-NORDISK A/S-SPONS ADR | -4.0% |